Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-07-07
DOI
10.3389/fphar.2017.00448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical chaperone treatment for galactosialidosis: Effect of NOEV on β-galactosidase activities in fibroblasts
- (2016) Mohammad Arif Hossain et al. BRAIN & DEVELOPMENT
- Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease
- (2016) Eugénie Laigre et al. CARBOHYDRATE RESEARCH
- The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat
- (2016) Elfrida R. Benjamin et al. GENETICS IN MEDICINE
- Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
- (2016) Derralynn A Hughes et al. JOURNAL OF MEDICAL GENETICS
- New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones
- (2016) Samantha J. Spratley et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation
- (2016) Devin Dersh et al. MOLECULAR BIOLOGY OF THE CELL
- Lysosomal storage disorders
- (2016) Michelle Grayson NATURE
- Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
- (2016) Aya Narita et al. Annals of Clinical and Translational Neurology
- The Biology of Proteostasis in Aging and Disease
- (2015) Johnathan Labbadia et al. Annual Review of Biochemistry
- Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening
- (2015) Sandra D.K. Kingma et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Eliglustat: A Review in Gaucher Disease Type 1
- (2015) Lesley J. Scott DRUGS
- Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations
- (2015) Mohammad Arif Hossain et al. JOURNAL OF HUMAN GENETICS
- UPR, autophagy, and mitochondria crosstalk underlies the ER stress response
- (2015) Daniela Senft et al. TRENDS IN BIOCHEMICAL SCIENCES
- Azasugar inhibitors as pharmacological chaperones for Krabbe disease
- (2015) Chris H. Hill et al. Chemical Science
- Pathogenesis, emerging therapeutic targets and treatment in sialidosis
- (2015) Alessandra D’Azzo et al. Expert Opinion on Orphan Drugs
- The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations
- (2014) Judit Macías-Vidal et al. FEBS Journal
- Impairment of homeostasis in lysosomal storage disorders
- (2014) Laura Segatori IUBMB LIFE
- Analysis of Mucolipidosis II/IIIGNPTABMissense Mutations Identifies Domains of UDP-GlcNAc:lysosomal Enzyme GlcNAc-1-phosphotransferase Involved in Catalytic Function and Lysosomal Enzyme Recognition
- (2014) Yi Qian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ER-associated degradation: Protein quality control and beyond
- (2014) Annamaria Ruggiano et al. JOURNAL OF CELL BIOLOGY
- Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators
- (2014) Ania C. Muntau et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases
- (2014) James A. Shayman et al. JOURNAL OF LIPID RESEARCH
- Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities
- (2014) Linda Ingemann et al. JOURNAL OF LIPID RESEARCH
- Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients
- (2014) Anna Sara Berardi et al. MOLECULAR GENETICS AND METABOLISM
- A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
- (2014) Franziska Richter et al. Neurotherapeutics
- Using pharmacological chaperones to restore proteostasis
- (2014) Ya-Juan Wang et al. PHARMACOLOGICAL RESEARCH
- The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease
- (2014) Richie Khanna et al. PLoS One
- Emerging novel concept of chaperone therapies for protein misfolding diseases
- (2014) Yoshiyuki SUZUKI PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Timing of diagnosis of patients with pompe disease: Data from the pompe registry
- (2013) Priya S. Kishnani et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Transgenic mice expressing human glucocerebrosidase variants: Utility for the study of Gaucher disease
- (2013) Angela Sanders et al. BLOOD CELLS MOLECULES AND DISEASES
- Autophagy Enhancer Carbamazepine Alleviates Memory Deficits and Cerebral Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease
- (2013) Lixi Li et al. Current Alzheimer Research
- TFEB regulates lysosomal proteostasis
- (2013) Wensi Song et al. HUMAN MOLECULAR GENETICS
- Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis
- (2013) K. Sandhoff et al. JOURNAL OF NEUROSCIENCE
- Chaperone Therapy for GM2 Gangliosidosis: Effects of Pyrimethamine on β-Hexosaminidase Activity in Sandhoff Fibroblasts
- (2013) Elena Chiricozzi et al. MOLECULAR NEUROBIOLOGY
- A Bicyclic 1-Deoxygalactonojirimycin Derivative as a Novel Pharmacological Chaperone for GM1 Gangliosidosis
- (2013) Tomoko Takai et al. MOLECULAR THERAPY
- Molecular genetic testing and the future of clinical genomics
- (2013) Sara Huston Katsanis et al. NATURE REVIEWS GENETICS
- Signals from the lysosome: a control centre for cellular clearance and energy metabolism
- (2013) Carmine Settembre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
- (2013) C. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones
- (2013) C. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emerging therapies and therapeutic concepts for lysosomal storage diseases
- (2013) Thomas Kirkegaard Expert Opinion on Orphan Drugs
- Enzyme Replacement Therapy for Lysosomal Diseases: Lessons from 20 Years of Experience and Remaining Challenges
- (2012) R.J. Desnick et al. Annual Review of Genomics and Human Genetics
- Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease
- (2012) Suhrad G. Banugaria et al. GENETICS IN MEDICINE
- New strategies for the treatment of lysosomal storage diseases (Review)
- (2012) GIANCARLO PARENTI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
- (2012) Frances M. Platt et al. JOURNAL OF CELL BIOLOGY
- Therapeutic chaperone effect of N-Octyl 4-Epi-β-valienamine on murine GM1-gangliosidosis
- (2012) Yoshiyuki Suzuki et al. MOLECULAR GENETICS AND METABOLISM
- The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis
- (2012) Erin M. O'Leary et al. MOLECULAR GENETICS AND METABOLISM
- Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
- (2012) Elfrida R Benjamin et al. MOLECULAR THERAPY
- Pharmacological Enhancement of α-Glucosidase by the Allosteric Chaperone N-acetylcysteine
- (2012) Caterina Porto et al. MOLECULAR THERAPY
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation
- (2011) Yohta Shimada et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Autophagy in the Cellular Energetic Balance
- (2011) Rajat Singh et al. Cell Metabolism
- Microautophagy: lesser-known self-eating
- (2011) Wen-wen Li et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Lacidipine Remodels Protein Folding and Ca2+ Homeostasis in Gaucher's Disease Fibroblasts: A Mechanism to Rescue Mutant Glucocerebrosidase
- (2011) Fan Wang et al. CHEMISTRY & BIOLOGY
- Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
- (2011) Michela Palmieri et al. HUMAN MOLECULAR GENETICS
- Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency
- (2011) Katsumi Higaki et al. HUMAN MUTATION
- Ex Vivoandin VivoEffects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
- (2011) Ying Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Endoplasmic Reticulum-associated Degradation Rescues Native Folding in Loss of Function Protein Misfolding Diseases
- (2011) Fan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal Structure of β-Hexosaminidase B in Complex with Pyrimethamine, a Potential Pharmacological Chaperone
- (2011) Katherine S. Bateman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mannose-6-phosphate pathway: A review on its role in lysosomal function and dysfunction
- (2011) Maria Francisca Coutinho et al. MOLECULAR GENETICS AND METABOLISM
- Efficacy of a Combined Intracerebral and Systemic Gene Delivery Approach for the Treatment of a Severe Lysosomal Storage Disorder
- (2011) Carmine Spampanato et al. MOLECULAR THERAPY
- Secondary Alterations of Sphingolipid Metabolism in Lysosomal Storage Diseases
- (2011) Alessandro Prinetti et al. NEUROCHEMICAL RESEARCH
- Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease
- (2011) Karen M. Ashe et al. PLoS One
- Insights into Krabbe disease from structures of galactocerebrosidase
- (2011) J. E. Deane et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts
- (2011) N. H. Pipalia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Inhibition of a Regulatory Subunit of Protein Phosphatase 1 Restores Proteostasis
- (2011) P. Tsaytler et al. SCIENCE
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- Chemical and Biological Approaches for Adapting Proteostasis to Ameliorate Protein Misfolding and Aggregation Diseases-Progress and Prognosis
- (2011) S. L. Lindquist et al. Cold Spring Harbor Perspectives in Biology
- Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases
- (2010) Yoshitaka Nagai et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Iminosugars past, present and future: medicines for tomorrow
- (2010) Graeme Horne et al. DRUG DISCOVERY TODAY
- Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders
- (2010) Alessandro Fraldi et al. EMBO JOURNAL
- Emerging drugs for lysosomal storage diseases
- (2010) Michael Beck EXPERT OPINION ON EMERGING DRUGS
- Effects of enzyme replacement therapy in Fabry disease—A comprehensive review of the medical literature
- (2010) Olivier Lidove et al. GENETICS IN MEDICINE
- Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases
- (2010) Einat B. Vitner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones
- (2010) W. C. Lee et al. JOURNAL OF NEUROSCIENCE
- An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
- (2010) Joe T.R. Clarke et al. MOLECULAR GENETICS AND METABOLISM
- Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs
- (2010) Etty Osher et al. MOLECULAR GENETICS AND METABOLISM
- Fabry disease
- (2010) Dominique P Germain Orphanet Journal of Rare Diseases
- Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease
- (2010) John Marshall et al. PLoS One
- Review: Therapeutic approaches for lysosomal storage diseases
- (2010) Gregory M. Pastores Therapeutic Advances in Endocrinology and Metabolism
- The values and limits of an in vitro model of Pompe disease: The best laid schemes o’ mice an’ men ……..†
- (2009) Shoichi Takikita et al. Autophagy
- Segregation analysis in a family at risk for the Maroteaux–Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism
- (2009) Alessandra Zanetti et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project
- (2009) P. Giraldo et al. HAEMATOLOGICA
- Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease
- (2009) Gaelle Douillard-Guilloux et al. HUMAN MOLECULAR GENETICS
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chaperone-mediated autophagy is defective in mucolipidosis type IV
- (2009) Bhuvarahamurthy Venugopal et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
- (2009) S. Strothotte et al. JOURNAL OF NEUROLOGY
- GM1-Ganglioside Accumulation at the Mitochondria-Associated ER Membranes Links ER Stress to Ca2+-Dependent Mitochondrial Apoptosis
- (2009) Renata Sano et al. MOLECULAR CELL
- The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
- (2009) Caterina Porto et al. MOLECULAR THERAPY
- Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
- (2009) Paul Saftig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lysosomal Storage Disorders in the Newborn
- (2009) O. Staretz-Chacham et al. PEDIATRICS
- Autophagy: A lysosomal degradation pathway with a central role in health and disease
- (2008) Eeva-Liisa Eskelinen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Lysosomal disorders: From storage to cellular damage
- (2008) Andrea Ballabio et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Treating lysosomal storage disorders: Current practice and future prospects
- (2008) Frances M. Platt et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
- (2008) Ting-Wei Mu et al. CELL
- Lysosomal Storage Diseases and the Blood-Brain Barrier
- (2008) David Begley et al. CURRENT PHARMACEUTICAL DESIGN
- Small molecule enhancers of autophagy for neurodegenerative diseases
- (2008) Sovan Sarkar et al. Molecular BioSystems
- Partial Restoration of Mutant Enzyme Homeostasis in Three Distinct Lysosomal Storage Disease Cell Lines by Altering Calcium Homeostasis
- (2008) Ting-Wei Mu et al. PLOS BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started